Chemours (CC) Is Up 8.2% After Taiwan TiO₂ Sale Boosts Liquidity Flexibility Has The Bull Case Changed?
Chemours (CC) has seen an 8.2% stock increase following the US$360 million sale of its Taiwan titanium dioxide facility. This sale is expected to significantly improve the company's liquidity and aid in debt reduction, addressing PFAS-related uncertainties. While the sale doesn't alter fundamental demand or margins, it provides much-needed balance sheet flexibility and helps manage legacy liabilities.
https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/chemours-cc-is-up-82-after-taiwan-tio-sale-boosts-liquidity